Quay lại
Giá Ascentage Pharma Group International (06855.HK)
Biểu đồ giá cổ phiếu 06855.HK
ASCENTAGE-B (06855.HK)
Ascentage Pharma Group International
HK$51.8
-3.44%
$-1.85
Thị trường chính thức: Jan 19, 09:46:08 HKT
Thống kê chính
Giá đóng cửa trước
$52.15
Giá mở cửa
$53.65
Phạm vi ngày
$51.8 - $54.1
Phạm vi 52 tuần
$31.35 - $95.35
Khối lượng
1.9M
Khối lượng trung bình
1.9M
EPS (TTM)
-4.04
Tỷ suất cổ tức
--
Vốn hóa thị trường
$19.2B
ASCENTAGE-B là gì?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Đặc điểm
Chiến lược giao dịch
Tài nguyên
© 2025 Finture Development Limited. All rights reserved
